Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neurons.
Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neurons.
复制标题
DOI:
10.1111/j.1471-4159.2010.07059.x
复制
发表时间:
2010-12
影响因子:
4.7
通讯作者:
Alkayed NJ
中科院分区:
文献类型:
--
作者:
Iliff JJ;Fairbanks SL;Balkowiec A;Alkayed NJ
Epoxyeicosatrienoic acids (EETs) are bioactive eicosanoids produced from arachidonic acid by cytochrome P450 epoxygenases. We previously described the expression of CYP-2J epoxygenase in rat trigeminal ganglion neurons and that EETs signaling is involved in cerebrovascular dilation resulting from perivascular nerve stimulation. Herein we evaluate the presence of the EETs signaling pathway in trigeminal ganglion neurons and their role in modulating the release of calcitonin gene-related peptide (CGRP) by trigeminal ganglion neurons. Liquid chromatography tandem mass spectrometry identified the presence of each of the four EETs regio-isomers within primary trigeminal ganglion neurons. Stimulation for one hour with the transient receptor potential vanilloid-1 channel agonist capsaicin (100 nmol/L) or depolarizing K+ (60 mmol/L) increased CGRP release as measured by ELISA. Stimulation-evoked CGRP release was attenuated by 30 min pre-treatment with the EETs antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE, 10 μmol/L). K+ stimulation elevated CGRP release 2.9 ± 0.3-fold above control levels, while in the presence of 14,15-EEZE K+-evoked CGRP release was significantly reduced to 1.1 ± 0.2-fold above control release (p<0.01 ANOVA, n=6). 14,15-EEZE likewise attenuated capsaicin-evoked CGRP release from trigeminal ganglion neurons (p<0.05 ANOVA, n=6). Similarly, pre-treatment with the CYP epoxygenase inhibitor attenuated stimulation-evoked CGRP release. These data demonstrate that EETs are endogenous constituents of rat trigeminal ganglion neurons and suggest that they may act as intracellular regulators of neuropeptide release, which may have important clinical implications for treatment of migraine, stroke and vasospasm after subarachnoid hemorrhage.
登录
查看更多内容
影响因子:
8.3
作者:
Alkayed, NJ;Narayanan, J;Harder, DR
通讯作者:
Harder, DR
影响因子:
8.3
作者:
Alkayed, NJ;Birks, EK;Harder, DR
通讯作者:
Harder, DR
影响因子:
4.8
作者:
Keserue, Benjamin;Barbosa-Sicard, Eduardo;Fleming, Ingrid
通讯作者:
Fleming, Ingrid
影响因子:
3.3
作者:
Chen, L.;Liu, C.;Liu, L.
通讯作者:
Liu, L.
DOI:
10.1152/ajpheart.01211.2007
发表时间:
2008-08-01
影响因子:
4.8
作者:
Liu, Xiaoguang;Li, Chunyuan;Koehler, Raymond C.
通讯作者:
Koehler, Raymond C.